Syqe is a pharma-tech company developing technologies that enable the precise delivery of a wide range of therapeutic molecules by inhalation.

Syqe Medical is a pocket-sized metered-dose cannabis inhaler designed to allow patients to reach the optimum balance between symptom relief and psycho-activities. The cannabis inhaler transforms psychoactive botanical into mainstream medical drugs. Utilizing selective 100-microgram dosing precision, real-time thermal and flow controllers, lung interfacing and inhalation-based drug delivery platform, enabling patients to recover diseases and regaining their quality of life.

MILESTONES

Founded: 2011

Arc investment: 2018

FOUNDERS

Perry Davidson

ARC TEAM

LATEST TWEETS

Syqe Medical Named to Fast Company’s Annual List of the World’s Most Innovative Companies for 2020

PR Newswire-GeneralĀ 11-Mar-2020